AUTL · Autolus Therapeutics plc
$2.15
-0.07 (-3.15%)
At close · Aug 14
Market Cap
$572.25M
Shares
266.16M
Autolus Therapeutics plc Earnings Call Transcripts
Every quarterly earnings call for Autolus Therapeutics plc (AUTL) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$10.09M
−$52.69M
'24 Q1
24-05-17
·
$
−$58.27M
'24 Q2
24-08-08
·
$
−$82.09M
'24 Q3
24-11-12
·
$29,000
−$27.61M
'24 Q4
25-03-20
▼11%
$8.98M
−$70.16M
'25 Q1
25-05-08
·
$20.92M
−$47.92M
'25 Q2
25-08-12
·
$21.19M
−$79.12M
'25 Q3
25-11-12
▲83655.2%
$24.29M
−$90.33M
'25 Q4
26-03-27
▲191.9%
$26.22M
−$71.60M
'26 Q1
26-05-14
LATEST
▲118.4%
$45.69M
−$39.11M
'26 Q2
26-08-11
Earnings call
FY26 · Q2
2026-08-11
Autolus Therapeutics plc Q2 FY2026 Earnings Call
Revenue
$45.69M
▲ 118.4% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-30
H.C. WAINWRIGHT 4TH ANNUAL CELL THERAPY VIRTUAL CONFERENCE
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-30
H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
JEFFERIES GLOBAL HEALTHCARE CONFERENCE
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
William Blair’s 46th Annual Growth Stock Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
WILLIAM BLAIR’S 46TH ANNUAL GROWTH STOCK CONFERENCE
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-14
Autolus Therapeutics plc Q1 FY2026 Earnings Call
Confident tone
Commercial launch of Ocastle
Gross margin improvement
Revenue and full-year guidance
Revenue
$26.22M
▲ 191.9% YoY Diluted EPS
$-0.27
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-27
Autolus Therapeutics plc Q4 FY2025 Earnings Call
Confident tone
Pipeline expansion (OB-Cell, Catalyst, Carlyle, Lumina)
Safety/efficacy in real-world setting
ROCCA real-world data consortium
Revenue
$24.29M*
▲ 83655.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Autolus Therapeutics plc Q3 FY2025 Earnings Call
Revenue
$21.19M
Diluted EPS
$-0.30
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Autolus Therapeutics plc Q2 FY2025 Earnings Call
Revenue
$20.92M
Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Autolus Therapeutics plc Q1 FY2025 Earnings Call
Revenue
$8.98M
▼ 11% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-20
Autolus Therapeutics plc Q4 FY2024 Earnings Call
Revenue
$29,000*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Autolus Therapeutics plc Q3 FY2024 Earnings Call
Revenue
$
Diluted EPS
$-0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Autolus Therapeutics plc Q2 FY2024 Earnings Call
Revenue
$
Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-17
Autolus Therapeutics plc Q1 FY2024 Earnings Call
Revenue
$10.09M
Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-14
Autolus Therapeutics plc Q4 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–17 of 17 earnings calls
Key facts
CIK
1730463
CUSIP
05280R100
13F (30d)
81 filings
79 filers
Visit website
Investor relations